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We have studied the effects of synthetic p-human atria1 natriuretic peptide (j?-hANP), an antiparallel dimer 
of a-hANP, on receptor binding and cGMP generation in cultured rat vascular smooth muscle cells and 
compared the effects with those of a-hANP. Characteristics of temperature-dependent binding and degrada- 
tion of 1Z51-~-hANP were similar to those of lZSI-a-hANP. Scatchard analysis indicated a single class of bind- 
ing sites for b-hANP with a maximal binding capacity one-half that of a-hANP. Parallel and antiparallel 
dimers were equipotent in inhibiting the binding and stimulating intracellular cGMP formation, of which 
the maximal effect was about one-half that of a-hANP. Reverse-phase high performance liquid chromato- 
graphy revealed that most of b-hANP added to cells was converted to a small molecular mass component 
corresponding to a-hANP after incubation. These data suggest that the less potent effect of p-hANP in re- 
ceptor binding and cGMP generation may be partly accounted for by the possible conversion of /J-hANP 
to a-hANP at the site of target cells. 
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1. INTRODUCTION 
In human atria, three distinct forms of human 
atria1 natriuretic peptide (hANP) have been iden- 
tified [1,2]: (Y (28 residues), p (56 residues), and y 
(126 residues). a-hANP is the major cardiac hor- 
mone with a potent natriuretic and vasoactive ac- 
tivity [l], while y-hANP having the sequence of 
cu-hANP at its C-terminus, is a precursor molecule 
for a-hANP [2,3]. In contrast, P-hANP comprises 
an antiparallel dimer of cu-hANP [2], although 
whether such a dimetric peptide processing occurs 
in vivo remains unknown. Recently, /?-hANP has 
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been synthesized and its biological activity has 
been determined [4,5]. Interestingly, natural [2] as 
well as synthetic fi-hANP [4,5] exhibits a slower 
onset and longer duration of action than a-hANP, 
the mechanism of which remains obscure. 
Using cultured rat vascular smooth muscle cells 
(VSMCs) which have specific receptors for ANP 
functionally coupled to the guanylate cyclase 
system [6], we have clarified the cellular 
mechanism of binding, internalization and 
degradation of a-rat (r) ANP [7]. To elucidate the 
mechanism by which ,&hANP acts on the target 
cell, we have studied the effects of synthetic ,& 
hANP on receptor binding and cGMP generation 
in cultured rat VSMCs in comparison with that of 
cr-hANP, and examined the change in molecular 
size of P-hANP coincubated with the cells. 
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2. MATERIALS AND METHODS 
2.1. Materials 
Antiparallel (,&hANP) and parallel dimers of a- 
hANP were synthesized by a conventional solution 
method as reported [4]. Synthetic cu-hANP was 
also obtained from Peptide Institute (Osaka, 
Japan). Iodination of a-hANP and ,&hANP was 
performed by the lactoperoxidase method [6] with 
specific activities of - 150 ,uCi/,ug and -50 &i/,ug, 
respectively. 
2.2. Binding experiment 
Rat aortic VSMCs were cultured and used in the 
experiments as reported [6]. Confluent cells 
(0.5-l x lo6 cells) were incubated with 1z51-~- 
hANP or ‘*‘I-,&-hANP in Hanks’ balanced salt 
solution, pH 7.4, containing 0.1% bovine serum 
albumin (binding medium) at 4°C for 3 h to 
minimize internalization and/or degradation of 
radioligand. After completion, cells were washed, 
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Fig. 1. Time course of specific binding of “‘I-(U-hANP 
and “‘1-fl-hANP to cultured rat VSMCs at 37°C and 
4°C. Confluent cells (lo6 cells) were incubated with 
2 nM “‘1-Cy-hANP (A) and ‘251-fl-hANP (B) at 37°C 
(0) or 4°C (0). At the indicated times, specific cell- 
bound radioactivity was determined; each point is the 
Fig.2. Time course of decrease of cell-bound ‘25I-~- 
hANP and ‘251-fi-hANP from cultured rat VSMCs at 
37°C and 4°C. After preincubation with 1 nM 1251~- 
hANP (A) and ‘251-/3-hANP (B) at 4°C for 3 h, cells 
were further incubated in fresh medium at 37°C (0) or 
4°C (0). At the indicated times, the cell-bound 
radioactivity was determined. The results are expressed 
as the percentage of binding at indicated time intervals 
to initial binding; each point is the mean of duplicate 
dishes. Specific binding of “‘I-a-hANP and 1251-@- 
hANP at zero time was 85% and 50% of total binding, 
mean of triplicate dishes. respectively. 
solubilized with NaOH, and cell-bound radioac- 
tivity was determined. Specific binding was defin- 
ed as total binding minus nonspecific binding in 
the presence of excess (3.2 x lo-’ M) unlabeled a- 
hANP or P-hANP. 
2.3. Internalization and degradation 
To study degradation, the cells were prein- 
cubated with radioligands at 4°C for 3 h, rinsed, 
and then incubated at either 37°C or 4°C; the cell- 
bound radioactivity was determined and 
trichloroacetic acid-insoluble radioactivity was 
also measured in aliquots of the medium. For 
analysis of internalization, prebound radioligand 
was dissociated with 0.1 M acetic acid treatment 
that only extracts surface-bound, but not inter- 
nalized ligands [7,8]. 
2.4. Determination of intracellular cGMP 
VSMCs were incubated with or without various 
doses of cu-hANP or fl-hANP at 37°C for 10 min 
in binding medium containing 0.5 mM 
methylisobutylxanthine [6]. Intracellular cGMP 
were determined by radioimmunoassay (RIA). 
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2.5. Chromatographic analysis 3. RESULTS 
To examine whether the change in molecular size 
of exogenous ,&-hANP occurs during incubation, 
the media in which P-hANP was coincubated with 
or without VSMCs at 37°C for 60 min were ap- 
plied to a Sep-Pak Cis cartridge (Waters Associate, 
Milford, MA) followed by washing with distilled 
water and elution with 5 ml of 86% ethanolM% 
acetic acid. The eluate was evaporated to dryness 
under nitrogen gas and subjected to reverse-phase 
high pressure liquid chromatography (HPLC) on a 
4.6 x 250 mm Zorbax ODS column (DuPont Co., 
Wilmington, DE) with a linear gradient from 10 to 
60% acetonitrile for 80 min. The flow rate was 
1 ml/min; l-ml fractions were collected. The 
eluates were dried and assayed for hANP by RIA 
as described in [9]. Lu-hANP RIA was performed 
using rabbit ant&-hANP antiserum that showed 
50% cross-reactivity with ,&-hANP on a molar 
Binding of ‘251_cy-hANP and “‘1-fi-hANP to 
cultured rat VSMCs showed almost similar 
temperature- and time-dependency (fig. 1); at 37°C 
binding of both radioligands rapidly reached to a 
maximum at 15-30 min and decreased thereafter, 
while their maximal binding at 4°C was slow 
(3-4 h) but about 3-4-fold greater than that at 
37°C. Specific binding of “‘I_Cy-hANP and ‘251-& 
hANP was 90-95% and 50-60% of total binding, 
respectively. The prebound radioactivity of either 
i2’I-cu-hANP or 1251-fl-hANP at 4°C after 
washing, decreased more rapidly upon warming 
the cells to 37°C than further incubation at 4°C 
(fig.2); most (> 80%) radioactive material released 
into medium at 37°C was trichloroacetic acid- 
soluble, while at 4°C it was exclusively 
trichloroacetic acid-insoluble. Furthermore, about 
one-third of cell-bound L251-Cy-hANP and “‘I-@ basis. 
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Fig.3. Saturable binding of ?_Cy-hANP and ‘2sI-,!3-hANP to cultured rat VSMCs. Confluent cells (lo6 cells) were 
incubated with various doses of lz51-Cy-hANP (A) and ‘251-fl-hANP (B) at 4°C for 3 h. Specific binding of ‘251-cy-hANP 
and ‘251-/3-hANP was 80-90% and 50-60% of total binding, respectively. Each point is the mean of two experiments. 
(Insets) Scatchard plots of binding data. KD, dissociation constant; B,,,, number of maximal binding sites per cell. 
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hANP at 37°C shifted to the acid-resistant com- 
partment, whereas at 4°C they were mostly loca- 
lized on the acid-extractable compartment (not 
shown). These experiments suggest that, after 
washing, the observed temperature-dependent 
decrease of cell-bound radioactivity is most 
probably due to internalization, degradation, and 
elimination of ligands rather than simple dissocia- 
tion from the cell surface as demonstrated [7]. 
An equilibrium binding of ‘251-cr-hANP and 
1251-@-hANP at 4°C was a saturable process 
(fig.3). Scatchard plots of the binding (fig.3, inset) 
revealed the presence of a single class of binding 
sites for both a-hANP and ,&hANP: the apparent 
dissociation constants (&) were almost the same 
(-2 x 10m9 M), while the maximal binding sites 
(B,,-& of &hANP (103000 sites/cell) was half that 
5xw IV 
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Fig.4. Competitive binding of rz51-cy-hANP and “‘I-fl- 
hANP to cultured rat VSMCs by unlabeled a-hANP and 
fl-hANP. Confluent cells (5 x 10’ cells) were incubated 
at 4°C for 3 h with 1 nM ‘251-cy-hANP (A) and ‘251-fl- 
hANP (B) in the absence and presence of various doses 
of unlabeled cu-hANP (o), its antiparallel (0) and 
parallel (A) dimers. Results are expressed as the 
percentage to specific binding in the absence of peptides 
(B,,); each point is the mean of duplicate dishes. Specific 
binding of “‘I--hANP and ‘251-fl-hANP was 98% and 
67% of total binding, respectively. 
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Fig.5. Effects of a-hANP and P-hANP on formation of 
intracellular cGMP in cultured rat VSMCs. Confluent 
cells (5 x lo5 cells) were incubated at 37°C for 10 min 
in the absence (@) and presence of various doses of (Y- 
hANP (o), its antiparallel (0) and parallel (A) dimers. 
Concentrations of intracellular cGMP were determined 
by RIA. Each point is the mean of three samples: bar 
shows SE. 
of cu-hANP (206000 sites/cell). Competitive 
binding of ‘251-cy-hANP (fig.4A) and tZ51-fi-hANP 
(fig.4B) by unlabeled a-hANP and its dimers was 
studied; parallel and antiparallel dimers equally in- 
hibited the binding of both radioligands with 
almost the same ICsO (-1-2 x lop9 M), but they 
were about 2-fold less potent than cr-hANP in 
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Fig.6. An elution profile of reverse-phase HPLC. The 
medium in which&hANP was coincubated with VSMCs 
at 37°C for 60 min was subjected to a reverse-phase 
HPLC. Concentrations of immunoreactive (IR) hANP 
were determined. Arrows denote the elution positions of 
standard cu-hANP (cu) and ,&hANP c4), respectively. 
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displacing both radioligands from their binding 
sites. 
As shown in fig.5, parallel and antiparallel 
dimers were equipotent in stimulating cGMP for- 
mation with an approximate ECso (-5 x lo-’ M) 
comparable to that of cu-hANP, whereas the max- 
imal stimulation on cGMP generation by two 
dimers was about one-half that by a-hANP. 
Reverse-phase HPLC of the medium in which fi- 
hANP was coincubated with cells revealed two im- 
munoreactive (IR) peaks (fig.6); a major peak 
comprising about two-third of total immunoreac- 
tivity emerged at the elution position of standard 
a-hANP, while a minor peak comigrated with 
standard /3-hANP. When &hANP was incubated 
in the same medium without cells, only the single 
IR peak coeluting with standard ,&hANP was 
observed (not shown). 
4. DISCUSSION 
It has recently been shown that synthetic p- 
hANP, an antiparallel dimer of cu-hANP, has 
biological properties similar to natural ,&hANP 
[4,5]. The present study first demonstrates that 
synthetic &hANP binds to cultured rat VSMCs in 
the same manner as a-hANP in terms of time- and 
temperature-dependency. Furthermore, the pre- 
sent binding experiments suggest that both (Y- 
hANP and P-hANP initially bound to cell-surface 
membranes are similarly internalized, degraded, 
and subsequently released into medium in a 
temperature-dependent manner. In fact, degrada- 
tion of cell-bound 1251-fi-hANP at 37°C was 
significantly blocked by pretreatment with 
lysosomotrophic drugs (NHdCl, chloroquine) and 
an autoradiographic study using electron 
microscopy revealed that grains of “‘1-fl-hANP 
were localized not only on the cell membrane, but 
also within lysosome-like structures at 37°C (un- 
published observations). Taken together, our data 
are consistent with the cellular mechanism of 
binding, internalization and degradation of p- 
hANP similar to that of cu-rANP as we have 
demonstrated [7]. Therefore, it seems unlikely that 
altered binding affinity and/or delayed degrada- 
tion of ,&hANP may be responsible for the observ- 
ed slower onset and longer duration of action by 
,&hANP [2,4,5]. 
While we have reported that only a small quanti- 
ty (2-3%) of ,&hANP is converted to a-hANP 
under in vitro conditions [4], the present study 
clearly shows that most of the P-hANP added to 
VSMCs in a serum-free condition is eventually 
converted to a small molecular sized component 
corresponding to a-hANP, suggesting the possible 
conversion from dimeric into monomeric form 
during incubation. Therefore, it seems likely that 
the observed slower onset and longer duration of 
&hANP action [2,4,5] may be in part accounted 
for by the conversion of ,&hANP to a-hANP at the 
site of target organs and/or in the circulation. 
However, whether the cleavage of intermolecular 
disulfide bonds of ,&hANP and reformation of an 
intramolecular disulfide bond of cr-hANP involve 
cell-mediated enzymatic processing remains to be 
determined. 
In the present studies, maximal binding capacity 
of ,&hANP is shown to be one-half that of cy- 
hANP, while the apparent binding affinity is 
almost the same. This is in accord with our result 
that the maximal stimulatory effects of in- 
tracellular cGMP formation by parallel and an- 
tiparallel dimers, although almost identical with 
one another, appear to be about half that by a- 
hANP. These data are also compatible with those 
of biological activities of P-hANPs [4,5]; parallel 
and antiparallel forms are equipotent but equally 
less potent than a-hANP in smooth muscle 
spasmolytic in vitro assays as well as natriuretic in 
vivo assays. Assuming that @hANP is fully con- 
vertible to a-hANP that interacts with its receptor 
and stimulates guanylate cyclase, P-hANP should 
be twice as active as a-hANP on a molar basis. 
However, this is not the case because &hANP 
bound only to half the receptor population. One 
would thus speculate that about one-fourth of the 
dimeric form may be convertible to the monomeric 
form to explain the less potent effect of fl-hANP in 
receptor binding and cGMP generation. The 
precise mechanism by which P-hANP is converted 
into cu-hANP in vivo remains to be elucidated. 
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